The role of reactive nitrogen species as biomarkers of disease severity in COVID-19
N. Konyalilar (Istanbul, Turkey), Ö. Kayalar (Istanbul, Turkey), D. Mortazavi (Istanbul, Turkey), H. Rajabi (Istanbul, Turkey), S. Korkunç (Istanbul, Turkey), S. Erkan (Istanbul, Turkey), T. Aksoy (Istanbul, Turkey), M. Gönenli (Istanbul, Turkey), F. Tokgöz Akyil (Istanbul, Turkey), S. Altin (Istanbul, Turkey), H. Bayram (Istanbul, Turkey)
Source: International Congress 2022 – Lung or long COVID: emerging insights into COVID-19 mechanisms
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Konyalilar (Istanbul, Turkey), Ö. Kayalar (Istanbul, Turkey), D. Mortazavi (Istanbul, Turkey), H. Rajabi (Istanbul, Turkey), S. Korkunç (Istanbul, Turkey), S. Erkan (Istanbul, Turkey), T. Aksoy (Istanbul, Turkey), M. Gönenli (Istanbul, Turkey), F. Tokgöz Akyil (Istanbul, Turkey), S. Altin (Istanbul, Turkey), H. Bayram (Istanbul, Turkey). The role of reactive nitrogen species as biomarkers of disease severity in COVID-19. 3775
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|